Adolore Biotherapeutics, Inc. | WebDisclosure

Basculer en Français

10472	Companies
220533	Keywords
149858	Articles
116623	Press releases

Headlines Articles Press releases Adolore Biotherapeutics, Inc.

Home
Companies
Adolore Biotherapeutics, Inc.

PRESS RELEASE

published on 05/16/2024 at 16:00, 2 years ago

Adolore BioTherapeutics Announces Publication Demonstrating Carbonic Anhydrase-8 Gene Therapy (rdHSV-CA8) Decreased Pain-Sensing Neuronal Excitability by Activating Kv7 Voltage-Gated Potassium Channels
Adolore BioTherapeutics announces groundbreaking findings in gene therapy for chronic pain treatment, highlighting the value of non-opioid analgesics and progress with IND-enabling studies

Adolore BioTherapeutics Chronic Pain Gene Therapy Non-opioid Analgesics IND-enabling Studies
BRIEF

published on 03/04/2024 at 16:05, 2 years 2 months ago

Adolore BioTherapeutics obtient un brevet américain pour la thérapie génique CA8* dans le traitement de la douleur chronique

Adolore BioTherapeutics Thérapie Génique Traitement De La Douleur Chronique Solutions Sans Opioïdes Délivrance De Brevet
BRIEF

published on 03/04/2024 at 16:05, 2 years 2 months ago

Adolore BioTherapeutics Secures U.S. Patent for CA8* Gene Therapy in Chronic Pain Treatment

Adolore BioTherapeutics Gene Therapy Chronic Pain Treatment Opioid-Free Solutions Patent Issuance
PRESS RELEASE

published on 03/04/2024 at 16:00, 2 years 2 months ago

Adolore BioTherapeutics Announces Issuance of First U.S. Patent Covering CA8* Gene Therapies to Treat Chronic Pain
Adolore BioTherapeutics licenses patent and CA8* gene therapy technology from the University of Miami for opioid-free chronic pain treatment. Company progresses toward clinical testing and commercialization

University Of Miami Adolore BioTherapeutics Chronic Pain Opioid-free Gene Therapy
PRESS RELEASE

published on 01/30/2024 at 16:00, 2 years 3 months ago

Adolore BioTherapeutics to Present at the 5th Annual National Institutes of Health (NIH) HEAL Initiative Scientific Meeting
Adolore BioTherapeutics will present at the 5th Annual NIH HEAL Initiative Scientific Meeting regarding the gene therapy program for chronic pain associated with knee osteoarthritis. The program is supported by NIH/NINDS HEAL UH3 Award

Adolore BioTherapeutics Chronic Pain NIH HEAL Initiative Gene Therapy Osteoarthritis
PRESS RELEASE

published on 12/05/2023 at 16:30, 2 years 5 months ago

Adolore BioTherapeutics Presents Promising Preclinical Data Supporting Its Innovative Gene Therapy to Treat Chronic Pain
Adolore BioTherapeutics presented preclinical data supporting its innovative CA8* gene therapy as a long-acting local analgesic for chronic osteoarthritis knee pain management, aiming to replace opioids

Adolore BioTherapeutics CA8* Gene Therapy Chronic Pain Opioid-free Preclinical Data
PRESS RELEASE

published on 10/11/2023 at 16:00, 2 years 7 months ago

Adolore BioTherapeutics to Participate at the Virtual Investor Ask the CEO Conference
PRESS RELEASE

published on 10/03/2023 at 15:15, 2 years 7 months ago

NIN/NINDS HEAL Program Grants Prestigious UH3 Award to the University of Miami, Principal Investigator Roy C. Levitt M.D, to Fund Clinical Development of Adolore BioTherapeutics’ Gene Therapy Program for the Treatment of Chronic Osteoarthritis Knee Pain

Accesswire

Published on 05/29/2026 at 15:50, 5 hours 56 minutes ago

Power Metallic Mines Announces Upsize of Brokered LIFE Offering for Gross Proceeds of up to C$30 Million
Published on 05/29/2026 at 14:30, 7 hours 16 minutes ago

Sarama Completes Tranche 1 Equity Placement and ASX Cleansing Notice
Published on 05/29/2026 at 14:30, 7 hours 16 minutes ago

Unusual Machines to Participate in June Investor Conferences
Published on 05/29/2026 at 14:20, 7 hours 26 minutes ago

Ansell Announces Greenovation(TM) Awards for Sustainability Leadership and Waste Reduction
Published on 05/29/2026 at 13:59, 7 hours 47 minutes ago

AIP Realty Trust Announces First Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 05/29/2026 at 21:30, 16 minutes ago

Mutares portfolio company F.lli Ferrari Holding has signed an agreement for the partial sale of its Benelux operations to HMF Group
Published on 05/29/2026 at 20:00, 1 hour 46 minutes ago

Brödernas publishes quarterly report for Jan-Mar 2026
Published on 05/29/2026 at 19:46, 1 hour 59 minutes ago

CPI PROPERTY GROUP publishes financial results for the first quarter of 2026
Published on 05/29/2026 at 19:27, 2 hours 18 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/29/2026 at 19:18, 2 hours 28 minutes ago

EQS-Adhoc: Ludwig Beck am Rathauseck-Textilhaus Feldmeier AG: Change to the shareholding structure

Les Echos

Published on 05/29/2026 at 21:42, 3 minutes ago

Descriptif du programme de rachat d'actions
Published on 05/29/2026 at 18:00, 3 hours 46 minutes ago

Recticel Group versnelt groei in isolatiepanelen met geïntegreerde isothermische oplossingen na overname Isopanel NV
Published on 05/29/2026 at 18:00, 3 hours 46 minutes ago

Recticel Group acquires Isopanel NV to deliver integrated solutions in the cold storage panels market
Published on 05/29/2026 at 17:52, 3 hours 53 minutes ago

Mandat de rachat d’actions
Published on 05/29/2026 at 17:52, 3 hours 53 minutes ago

Share buyback mandate

View all LES ECHOS COMFI WIRE